VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,426 | -24.8% | 27,980 | -44.7% | 0.02% | -27.3% |
| Q1 2023 | $1,897 | +44.6% | 50,626 | +85.0% | 0.02% | +37.5% |
| Q4 2022 | $1,312 | -99.6% | 27,370 | +79.2% | 0.02% | +220.0% |
| Q3 2022 | $367,000 | +3.1% | 15,272 | -6.6% | 0.01% | +25.0% |
| Q2 2022 | $356,000 | +47.1% | 16,345 | +61.0% | 0.00% | +300.0% |
| Q4 2021 | $242,000 | -62.8% | 10,155 | -60.4% | 0.00% | -66.7% |
| Q3 2021 | $651,000 | +389.5% | 25,670 | +282.3% | 0.00% | +200.0% |
| Q1 2021 | $133,000 | – | 6,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
| Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
| Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
| Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
| Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
| RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
| Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
| TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |